NCT01562275View on ClinicalTrials.gov

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Neoplasms
Interventions
DRUG

Ipatasertib

multiple doses

DRUG

Cobimetinib

multiple doses

Trial Locations (5)

37203

Nashville

46010

Valencia

48201

Detroit

02215

Boston

08035

Barcelona

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY